-+ 0.00%
-+ 0.00%
-+ 0.00%
Nasus Pharma Reports First Half 2026 Financial Results and Provides Business Update
Share
Listen to the news

Appointed Pharma Industry Veteran Brendan O’Grady as Chief Executive Officer

Company on Track to Advance Clinical Programs to Key Second Half 2026 Milestones

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending